GRANULES INDIA
Back to Income Statement
|
GRANULES INDIA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹517 Cr | ₹413 Cr | ₹5,495 Cr | ₹335 Cr | ₹236 Cr |
What is the latest Consolidated Net Profit of GRANULES INDIA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹517 Cr |
Mar2023 | ₹413 Cr |
Mar2022 | ₹5,495 Cr |
Mar2021 | ₹335 Cr |
Mar2020 | ₹236 Cr |
How is Consolidated Net Profit of GRANULES INDIA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹517 Cr | 25.16 | |
Mar2023 | ₹413 Cr | -92.49 | |
Mar2022 | ₹5,495 Cr | 1,538.23 | |
Mar2021 | ₹335 Cr | 41.87 | |
Mar2020 | ₹236 Cr | - |
Compare Consolidated Net Profit of peers of GRANULES INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GRANULES INDIA | ₹12,510.6 Cr | -2.5% | -12.6% | 15.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,395.0 Cr | -4.1% | -9.8% | 8.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,422.0 Cr | -2.9% | -0.3% | 63.8% | Stock Analytics | |
CIPLA | ₹119,252.0 Cr | 0.1% | 4.4% | 2.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹101,889.0 Cr | -1.3% | -6.5% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,191.9 Cr | -4% | -5.9% | -7.8% | Stock Analytics |
GRANULES INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GRANULES INDIA | -2.5% |
-12.6% |
15.3% |
SENSEX | -0.8% |
-1.6% |
3.1% |
You may also like the below Video Courses